InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+3.0%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Hopfner Robert Lorne, Director. Director active across 2 companies, notably Rallybio Corp. Aggregated, 7 filings have been recorded. Split: 5 buys · 0 sell. Total volume traded: €7.1m. Activity tracked since 19 April 2022. The latest transaction was filed on 1 August 2023 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations7 total
119,048 shares@ US$4.807.3% of flowCommon StockSEC:0000950170-23-038268:0
Ideal exit: 27 Apr 2024 (T+270)
219,230 shares@ US$6.4818.3% of flowCommon StockSEC:0001209191-23-029521:0
Ideal exit: 5 Feb 2024 (T+270)
344,592 shares@ US$4.537920.3% of flowCommon StockSEC:0001209191-23-021647:0
Ideal exit: 24 Dec 2023 (T+270)
51,074 shares@ US$3.69522.5% of flowCommon StockSEC:0001209191-23-021559:0
Ideal exit: 22 Dec 2023 (T+270)
1,070,000 shares@ US$3.69100.0% of flowCommon StockSEC:0001209191-22-024919:0
Ideal exit: 14 Jan 2023 (T+270)
1,694,388 sharesCommon StockSEC:0000899243-21-031635
1,694,388 sharesCommon StockSEC:0000899243-21-031635:0
7 of 7 declarations
About Hopfner Robert Lorne
Robert Lorne Hopfner is a Board Member at Rallybio Corp and Inozyme Pharma, Inc. He brings expertise in corporate governance and strategy. Robert is involved in key decisions that influence the direction and performance of these companies.
